Descrizione del progetto
Migliorare il trattamento della multimorbilità con un approccio pre-commerciale basato sugli appalti
La multimorbilità è in aumento, trainata dall’invecchiamento della popolazione, e in Europa ne soffrono decine di milioni di persone. Si avverte l’urgente necessità di una tecnologia che consenta cure, trattamenti, somministrazione e supporto specifici. Il progetto Carematrix PCP, finanziato dall’UE, svilupperà una tecnologia innovativa che consenta di fornire cure più olistiche e predittive e benefici di supporto, lavorando in stretto dialogo con pazienti, operatori sanitari e settori industriali, in linea con un approccio basato su appalti pre-commerciali che include processi di co-creazione, gestione dei contratti, valutazione e test, nonché supporto allo sviluppo aziendale. L’obiettivo del progetto è di accorciare i tempi trascorsi nelle strutture di cura, ridurre gli errori clinici e aumentare la sicurezza del paziente.
Obiettivo
Over 50m people suffer from multimorbidity (PMM) in Europe. Recent reviews find that PMM experience a range of system and professional-related issues with care delivery. In part, this is because current investments in process-based delivery means delivering healthcare within single diagnoses tracks/silos. For PMMs this does not reflect real-world conditions.
No technology is available today that enables the specific care, treatment, administration and support needed for this target group. Breakthrough solutions will classify the individual according to their co/multimorbidities and medications. But this needs to be developed in close dialogue between PMM, care providers and industry sectors based upon a strong demand driven approach in a PCP.
Accordingly, the CareMatrix Buyers Group (SE, NO, ES) challenge the market to develop innovative technology that enables more predictive care and support benefits for PMM. This is achieved with 6 project objectives summarised as PCP: stakeholder engagement, roadmap, Call, implementation, next steps and; profiling and outreach via IFIC.
The methodology can be summarised as PCP: framing actions (PCP preparation, use of UCD principles and practice); implementation actions (Phases 1-3 contract management, support, evaluation and testing) and Market Preparation actions (business development support for Phase 3 suppliers, standards, initial PPI preparation).
Direct benefits include:
• 20% reduction in time spent for visits to care facilities
• Improvements from baseline in at least 75% of aspects of care as identified using PREM surveys
• 50% fewer patient data-related incidents (increased patient safety) between organizations
• No of clinical errors reduced by 30%;
Underpinning the CareMatrix solution(s) with integrated innovation (supportive policy priorities, organisational and social innovations) will optimise the potential of those solutions to produce savings of 10% in health care expenditure for PMM.
Campo scientifico
Parole chiave
Programma(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SC1-2020-Single-Stage-RTD
Meccanismo di finanziamento
PCP - Pre-Commercial ProcurementCoordinatore
223 81 Lund
Svezia